Vivos Therapeutics, Inc.
VVOSCIK 0001716166 · Surgical & Medical Instruments & Apparatus · Nasdaq
- Vivos BioTechnologies, Inc. (until 2017-09-29)
Revenue (TTM)
$18.76M
+16.0% YoY
Q1 May 2026
Net Income (TTM)
−$21.96M
−90.1% YoY
Q1 May 2026
EPS Diluted (TTM)
−$2.01
+6.8% YoY
Q1 May 2026
Gross Margin
56.6%
Q1 May 2026
Operating Margin
-107.3%
Q1 May 2026
Net Margin
-117.1%
Q1 May 2026
Free Cash Flow (TTM)
−$16.39M
Q1 May 2026
Cash
$2.11M
Q1 May 2026
Total Debt
$7.72M
Q1 May 2026
Shares Outstanding
13.89M sh
Q1 May 2026